{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:22:32Z","timestamp":1782591752409,"version":"3.54.5"},"reference-count":19,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.5551\/jat.56093","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T22:05:59Z","timestamp":1591221959000},"page":"169-180","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial"],"prefix":"10.5551","volume":"28","author":[{"given":"Takanari","family":"Kitazono","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Women's Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nippon Medical School, Tama-Nagayama Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Department of Stroke Neurology, National Hospital Organization Osaka National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tanahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University International Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayasu","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sakai City Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Minematsu","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Mie University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nanto","sequence":"additional","affiliation":[{"name":"Nishinomiya Municipal Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Waseda University Faculty of Science and Engineering"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Shirai","sequence":"additional","affiliation":[{"name":"Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Abe","sequence":"additional","affiliation":[{"name":"Biostatistics & Data Management Department, R&D Division, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PRASTRO-I Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators: Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol, 2017; 16: 301-310","DOI":"10.1016\/S1474-4422(17)30038-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Meng X, Wang C, Zhao X, Soo Y, Johnston SC, Wang Y; CHANCE Investigators: Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Neurology, 2015; 85: 1154-1162","DOI":"10.1212\/WNL.0000000000001972"},{"key":"3","unstructured":"3) Ogawa A: The Japan Stroke Society: Committee on guidelines for the management of stroke. Japanese guidelines for the management of stroke 2015. Kyowa Kikaku, Tokyo, 2015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke, 2014; 45: 2160-2236","DOI":"10.1161\/STR.0000000000000024"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corr\u00e0 U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, L\u00f8chen ML, L\u00f6llgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis, 2016; 252: 207-274","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E; PRINCIPLE-TIMI 44 Investigators: Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation, 2007; 116: 2923-2932","DOI":"10.1161\/CIRCULATIONAHA.107.740324"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nagao T, Toyoda K, Kitagawa K, Kitazono T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y, Ogawa A: A noninferiority confirmatory study of prasugrel versus clopidogrel in Japanese patients with ischemic cerebrovascular disease: rationale and study design for a randomized controlled trial. Expert Opin Pharmacother, 2018; 19: 529-535","DOI":"10.1080\/14656566.2018.1444029"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ogawa A, Toyoda K, Kitagawa K, Kitazono T, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y; PRASTRO-I Study Group: Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I). Lancet Neurol, 2019; 18: 238-247","DOI":"10.1016\/S1474-4422(18)30449-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993; 24: 35-41","DOI":"10.1161\/01.STR.24.1.35"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahl\u00f6f B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group: Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med, 2008; 359: 1238-1251","DOI":"10.1056\/NEJMoa0805002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med, 2007; 357: 2001-2015","DOI":"10.1056\/NEJMoa0706482"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N, Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H, Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T, Matsumoto M; J-STARS Collaborators: The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Openlabel, Parallel-group Study. EBioMedicine, 2015; 2: 1071-1078","DOI":"10.1016\/j.ebiom.2015.08.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Shi Y, Wardlaw JM: Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke Vasc Neurol, 2016; 1: 83-92","DOI":"10.1136\/svn-2016-000035"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Benavente OR, Hart RG, McClure LA, McClure LA, Szychowski JM, Coffey CS, Pearce LA: Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med, 2012; 367: 817-825","DOI":"10.1056\/NEJMoa1204133"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Amarenco P, Lavallee PC, Labreuche J, Albers GW, Bornstein NM, Canh\u00e3o P, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina C, Rothwell PM, Sissani L, \u0160koloud\u00edk D, Steg PG, Touboul PJ, Uchiyama S, Vicaut \u00c9, Wong LK; TIAregistry.org Investigators: One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med, 2016; 374: 1533-1542","DOI":"10.1056\/NEJMoa1412981"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 2004; 364: 331-337","DOI":"10.1016\/S0140-6736(04)16721-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Higgins P, MacFarlane PW, Dawson J, McInnes GT, Langhorne P, Lees KR: Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke: a randomized, controlled trial. Stroke, 2013; 44: 2525-2531","DOI":"10.1161\/STROKEAHA.113.001927"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA: Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol, 1989; 25: 382-390","DOI":"10.1002\/ana.410250410"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E: Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. J Am Coll Cardiol, 2008; 51: 2028-2033","DOI":"10.1016\/j.jacc.2008.04.002"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/2\/28_56093\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T04:01:03Z","timestamp":1612584063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/2\/28_56093\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.56093","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}